Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
01/2006
01/26/2006CA2574666A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
01/25/2006CN1724522A Preparation method of methazolamide
01/24/2006US6989402 Thyroid receptor ligands and method II
01/19/2006US20060014962 Thiadiazole compound and use thereof
01/19/2006US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus
01/19/2006US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/18/2006EP1616866A1 M-stage kinesin inhibitor
01/18/2006EP0973727B8 Activated iododerivatives for the treatment of cancer and aids
01/18/2006CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/12/2006US20060009500 Antiproliferative 1,2,3-thiadiazole compounds
01/11/2006EP1613610A1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
01/11/2006EP1107951B1 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group
01/11/2006CN1720240A Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
01/05/2006WO2006002284A1 Ubiquitin ligase inhibitors
01/05/2006US20060004196 Method for producing heterocyclic fluoroalkenyl sulfones
01/05/2006US20060004063 Inhibitors of HCV NS5B polymerase
01/05/2006US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/04/2006EP1611091A1 Novel compounds
12/2005
12/29/2005US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists
12/29/2005US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
12/28/2005EP1608633A1 Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005CN1714123A Thermoplasltic elastomer composition
12/28/2005CN1714086A 1,2,4-thiadiazole compound and its harmful arthropod-controlling application
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282818 Ubiquitin ligase inhibitors
12/22/2005US20050282801 Novel phenantridine analogues and uses thereof
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/14/2005EP1603891A1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/13/2005US6974829 Succinoyl aminopyrazoles and related compounds
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005115995A1 Amine compound and organic electroluminescent element employing the same
12/08/2005WO2005058298B1 Fk228 analogs and their use as hdac-inhibitors
12/08/2005WO2004058911A3 Organic electroluminescent element
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005US20050267300 Processes and reagents for oligonucleotide synthesis and purification
12/01/2005US20050266496 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1185518B1 Alpha-phenyl-beta-ketosulfone
11/30/2005CN1703413A Thiadiazole compound and use thereof
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005US20050256173 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (I)
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1595543A2 Antineoplastic pharmaceutical compositions comprising taurolidine or taurultam and 5-fluorouracil
11/16/2005EP1594497A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
11/16/2005EP0977738B1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6964959 Use of a methylol-containing compound to treat tumors
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005WO2005077124A3 Compounds and compositions as lxr modulators
11/10/2005WO2005058298A3 Fk228 analogs and their use as hdac-inhibitors
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103020A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005CA2563615A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/02/2005EP1591834A2 Azine-based charge transport materials
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005CN1690868A Azine-based charge transport materials
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
10/2005
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2004016213A3 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050238978 Azine-based charge transport materials
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005CN1688559A 1, 2, 4-thiadiazole compounds and use thereof
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/20/2005WO2005097817A2 Process and reagents for oligonucleotide synthesis and purification
10/20/2005WO2005097117A1 Thiadiazolidinones as gsk-3 inhibitors
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234111 D-homo-17-chlor-16(17)-ene steroids
10/20/2005CA2561741A1 Processes and reagents for oligonucleotide synthesis and purification
10/20/2005CA2559740A1 Thiadiazolidinones as gsk-3 inhibitors
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 100